Rockwell Medical is a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease and chronic kidney disease. Rockwell Medical's exclusive renal drug therapy, TRIFERIC, supports disease management initiatives to improve the quality of life and care of dialysis patients and is intended to deliver safe and effective therapy, while decreasing drug administration costs and improving patient convenience. Rockwell also offers Calcitriol vitamin-D-injection and CitraPure® citric-based concentrate.